Health ❯ Healthcare

Oncology

Cancer Treatment Breast Cancer Lung Cancer Clinical Trials Cancer Research Patient Care Pediatric Oncology Cancer Treatments Lymphoma Tumor Biology

KRAS Pill Doubles Survival in Trial as Pancreatic Cancer Vaccine Advances

The early wins hint at a turn toward precision tools in a cancer with few options.

HHS Chief Distances From FDA Replimune Denial as Oncologists Dispute Review

Merck and Other Drugmakers Weigh Bids for Inhibrx’s Keytruda-Linked Cancer Drug

AI Pathomics Tool Beats PD-L1 at Predicting Lung Cancer Immunotherapy Benefit

Revolution Medicines’ Pancreatic Cancer Drug Lands ASCO Plenary After Phase 3 Survival Gain

EMA Validates Astellas Bid to Add Padcev–Keytruda Combo for Perioperative Muscle-Invasive Bladder Cancer

Single CAR T Infusion Clears Residual Disease in High-Risk Smoldering Myeloma Trial

First-in-Human SynKIR-110 Shows Safe Profile and Early Activity in Solid Tumors

ACP Recasts Breast Screening With Biennial Mammograms at Ages 50–74

PerturbFate Maps Shared Drivers of Melanoma Drug Resistance

Dosing Disputes, Counterfeits, and a Patent Wall Put Keytruda Under Fresh Scrutiny

Revolution Medicines Drug Nearly Doubles Survival in Phase 3 Pancreatic Cancer Trial

FDA Grants Priority Review to Ifinatamab Deruxtecan for Pretreated Small Cell Lung Cancer

Allogene Soars on Early ALPHA3 Readout Showing Strong MRD Edge and Clean Safety

IDEAYA Combo Doubles Progression-Free Survival in Uveal Melanoma Trial

Transgene Completes Phase 2 Randomization for Personalized Cancer Vaccine TG4050

Cadonilimab Plus Chemo Delivers Strong Phase 2 Signal in Frontline Endometrial Cancer

FDA Rejects Replimune’s Melanoma Virus Therapy Again for Insufficient Evidence

New Study Explains Why BET Drugs Falter by Splitting BRD2 and BRD4 Roles

Gilead to Acquire Tubulis for Up to $5 Billion to Boost Cancer ADC Pipeline